Sepsis诊断市场份额，规模，趋势，行业分析报告，由产品（仪器，血液培养媒体，测定套件和试剂，软件）;通过技术;通过病原体;通过测试类型;按地区;分部预测，2020 - 2027年

报告摘要

The global sepsis diagnostics market was valued at USD 548.2 million in 2019 and is expected to grow at a CAGR of 8.5% during the forecast period. The key factors responsible for the market growth are the unattended sepsis cases in the low and middle-income countries coupled with the construction of government hospitals in the remote rural areas, innovations in the sepsis diagnostic with the advent of new biomarkers, and the introduction of technologically advanced sepsis diagnostic automated systems in the market.

了解有关此报告的更多信息：请求样本页面

Sepsis is a severe medical condition triggered by a strong immune response with the onset of any infection. The high prevalence across the globe posing a huge threat to humans. As per the statistics published by the WHO, in 2018, over 30 million individuals, worldwide suffered from sepsis, with an alarming annual mortality rate of 5 percent. It also stated that each year around 3 million infants and 1.2 million children suffer from this condition. This demand-side factor is crucial for market growth.

For instance, in October 2018, the U.S.-based Duke University Hospital introduced “Sepsis Watch” an AI system to identify the onset of early stages of sepsis for patients in the emergency and intensive care unit. The system identifies health indicators such as medical histories, lab tests, and vital signs. The system was able to pull the patient’s data every 5 minutes to evaluate medical conditions. It alerts the hospital’s nurse to make informed decisions based on a patient’s condition using standard protocols by the Surviving Sepsis Program introduced in the market.

Industry Dynamics

Growth Drivers
败血症市场增长的主要触发因素包括医院获得的感染（HAI），特别是在晚年，婴儿和患有一些共同生命的人。根据疾病和管制中心（CDC）的估计，每年近170万人患有HAI，约99,000名患者因美国医疗保健而死亡。因此，人民的经济负担是巨大的，大多数在市场上的收入均从败血症诊断和治疗程序中搅拌。

The current tests being time-consuming, with an average test time of up to 72 hours to decipher final results and key observations. Thereby, demand for the point of care and rapid sepsis test kits in the market for early diagnosis could save millions of lives. In line with this, in February 2019, the researchers studying at the University of Strathclyde developed a cost-effective sepsis diagnostic system. It uses the micro-electrode inserted into the blood vessel and analyzes blood metrics in two and a half minutes. The key players in the market-place are collaborating with the university to make the developed system commercially viable, and the companies can have a first-mover advantage.

符合这一点，行业活动增加，例如，在2020年9月，巴塞罗那的循环诊断，开发了一个护理点诊断平台。根据公司的索赔，产品将取代传统的血液培养分析方法。基本思想是通过基于血液的标记鉴定细菌感染，并且能够以99％的精度率为2小时提供测试结果。根据本公司索赔，该系统的诊断费用为70美元。早期诊断，也对败血症治疗的医院费用较少。根据市场上的独立调查，2018年，入学后脓毒症待遇的成本近22,000美元，与每位患者为期70,000美元，为医院收购的败血症。

SEPSIS诊断市场报告范围

The market is primarily segmented on the basis of product, technology, pathogen, testing type, and region.

由产品	By Technology	By Pathogen	By Testing Type	按地区
Instruments Blood Culture Media 测定套件和试剂 Software	Microbiology 分子诊断 生物标志物 免疫测定 流式细胞仪	Bacterial Sepsis 革兰氏阳性细菌 革兰氏阴性细菌 Fungal Sepsis Others	实验室测试 PoC测试	北美（美国，加拿大） 欧洲（法国，德国，英国，意大利，西班牙，荷兰，奥地利） Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea) 拉丁美洲（巴西，墨西哥，阿根廷） 中东和非洲（沙特阿拉伯，阿联酋，以色列，南非）

了解有关此报告的更多信息：请求样本页面

Insight by Product

根据该产品，全球诊断市场分为仪器，血液培养基，测定套件和试剂，以及软件。2019年，估计血液文化媒体估计为最大的份额，并预计将在研究期间保持其优势。这是由于血液文化仍然是大多数医生最优秀的最具成本效益和最具金的标准方法。

工具和试剂市场预期to showcase the highest growth rate over the forecast period. This is attributed to the continuously rising demand for reagents & kits for diagnostic, particularly in the developed economies. As per the study published by the American Medical Association (AMA), by February 2019, sepsis was a major death cause in the hospitals and impacted the lives of around 1.7 million individuals in the U.S. Thus, with the need for rapid diagnosis in the hospitals and clinics, the sale of reagent and kits is bound to increase in the market.

技术洞察力

On the basis of diagnostic technology, the microbiology segment held a major market share in the global market, in 2019. The segment’s high share is due to the fact that microbiology involves the identification and detection of microbes in the blood culture media, with the help of well-trained microbiologists. The molecular diagnostic segment is projected to exhibit the highest CAGR over the study period. The technique is considered as a gold standard after blood culture in pathogen identification.

Geographic Overview

北美市场占全球市场最大的收入持有人之一，并且可能在研究期间保持其优势。诊断测试的有利报销情景，发达的医疗和临床基础设施，主要参与者在该国运营的智力能力。

此外，该国拥有高可支配收入和支出模式，必然会吸引市场关键诊断公司的既得利益。根据基于美国的CDC国家医疗保健安全网络的卫生经济学家报告的数据，每年的HAIS的年度负担仅支付28美元至450亿美元。betway体育亚洲版入口

预计亚太市场将在预计的诊断期间表现出有利可图的增长率。医院和非医院环境中脓毒症患者的上升案例，以及越来越多的医学素养和认识，保险普及率上升，以及该地区各国各国农村地区的人均医疗费用上升。根据PLO的估计，2019年，印度对临床脓毒症发病率很高，而且也影响了患者的生命。

竞争洞察力

Some of the major players operating the market include bioMérieux, Axis-Shield Diagnostics, Becton Dickinson, Danaher Corporation, Abbott Laboratories, Luminex, Thermo Fisher Scientific, EKF Diagnostics, Immunexpress, Bruker, Roche Diagnostics, T2 Biosystems, Response Biomedical, and CytoSorbents.